Showing results (21-30 of 460) with videos related to
Sort By:
Pageof 46
Expert Review of Precision Medicine and Drug Development|July 19, 2016
Use of big data in drug development for precision medicineRosa S Kim, Nicolas Goossens, Yujin HoshidaAdvanced Drug Delivery Reviews|May 17, 2017
Hepatic stellate cells as key target in liver fibrosisTakaaki Higashi, Scott L Friedman, Yujin HoshidaCurrent Hepatology Reports|March 25, 2017
Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Nicolas Goossens, C Billie Bian, Yujin HoshidaJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
DNA microarrays in clinical oncologySridhar Ramaswamy, Todd R GolubHepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2020
Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseasesNaoto Fujiwara, Tongqi Qian, Bhuvaneswari Koneru, et al.Journal of Hepatology|October 4, 2011
Genomic risk of hepatitis C-related hepatocellular carcinomaYujin Hoshida, Bryan C Fuchs, Kenneth K TanabeTranslational Cancer Research|July 28, 2015
Cancer biomarker discovery and validationNicolas Goossens, Shigeki Nakagawa, Xiaochen Sun, et al.Current Cancer Drug Targets|August 10, 2012
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesYujin Hoshida, Bryan C Fuchs, Kenneth K TanabeJournal of Liver Cancer|December 5, 2024
Molecular and immune landscape of hepatocellular carcinoma for therapeutic developmentHiroyuki Suzuki, Sumit Mishra, Subhojit Paul, et al.Nature Reviews. Genetics|June 17, 2015
An ecosystem of cancer cell line factories to support a cancer dependency mapJesse S Boehm, Todd R GolubPageof 46